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Synopsis
N-terminal acetylation, catalysed by N-terminal acetyltransferases (NATs), is among the most common protein modi-
fications in eukaryotes and involves the transfer of an acetyl group from acetyl-CoA to the α-amino group of the first
amino acid. Functions of N-terminal acetylation include protein degradation and sub-cellular targeting. Recent findings
in humans indicate that a dysfunctional Nα-acetyltransferase (Naa) 10, the catalytic subunit of NatA, the major NAT,
is associated with lethality during infancy. In the present study, we identified the Danio rerio orthologue zebrafish Naa
10 (zNaa10). In vitro N-terminal acetylation assays revealed that zNaa10 has NAT activity with substrate specificity
highly similar to that of human Naa10. Spatiotemporal expression pattern was determined by in situ hybridization,
showing ubiquitous expression with especially strong staining in brain and eye. By morpholino-mediated knockdown,
we demonstrated that naa10 morphants displayed increased lethality, growth retardation and developmental abnor-
malities like bent axis, abnormal eyes and bent tails. In conclusion, we identified the zebrafish Naa10 orthologue and
revealed that it is essential for normal development and viability of zebrafish.
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INTRODUCTION
Nα-terminal acetylation (Nt-acetylation), the process in which
an acetyl group from acetyl-CoA is transferred on to the α amino
group of a protein’s first amino acid residue, occurs on the major-
ity of eukaryotic proteins [1–4]. Though ubiquitous, its function
has been the subject of some controversy. Whereas earlier work
suggested that Nt-acetylation protects proteins from degradation
[5,6], possibly by blocking ubiquitination of the N-terminus [7],
more recent studies demonstrate that this modification is func-
tionally implicated in targeting proteins for degradation via a
novel branch of the N-end rule pathway, probably as a way of
degrading misfolded proteins or maintaining appropriate stoi-
chiometries of protein subunits [8–10]. Other direct roles for
Nt-acetylation include modulating protein complex formation
[11], preventing post-translational endoplasmic reticulum (ER)-
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translocation [12], as well as regulating protein function and
subcellular localization [13–15].
In eukaryotes, there are up to six N-terminal acetyltransferases
(NATs), termed NatA–NatF, serving as the catalytic machinery
for Nt-acetylation. Each NAT is composed of one or more spe-
cific subunits and is active towards specific subsets of proteins,
mostly determined by the N-terminal amino acid sequence of
the substrate [16]. In terms of the number of substrates, the ma-
jor NAT is NatA, which co-translationally acetylates N-termini
starting with a small amino acid (Ala, Cys, Ser, Thr, Val, Cys),
after the initiator methionine has been removed. Its substrate
pool thus consists of almost 40 % of all N-termini in humans
[1]. The NatA complex consists of the catalytic subunit Nα-
acetyltransferase (Naa)10 (Ard1, arrest defective 1) and the aux-
iliary subunit Naa15 (NATH, N-acetyltransferase human/Nat1)
[17–19]. Naa50 (San, separation anxiety) is also found asso-
ciated with the complex in yeast [20], Drosophila [21] and
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humans [22], as is the huntingtin yeast two-hybrid protein K in
humans [23]. Free, non-complexed Naa10 was previously found
to post-translationally Nt-acetylate the acidic β- and γ -actins
[24]. Naa10 also possesses Nt-propionyltransferase activity [25],
lysine acetyltransferase activity [26–28] and was shown to act
as a binding partner to other proteins, modulating their activ-
ity in an acetyltransferase-independent manner [29,30]. Com-
ponents of the NatA complex, in particular Naa10, have been
linked to carcinogenesis, in both tumour promoter and tumour
suppressor capacities [31]. Saccharomyces cerevisiae naa10Δ
and naa15Δ strains show identical phenotypes with mating de-
fects and temperature sensitivity, though they remain viable [19].
Loss of Naa10 function is lethal, however, in Drosophila [32],
Trypanosoma brucei [33] and Caenorhabditis elegans [34]. The
recently identified Ogden syndrome, where boys harbouring a
mutation in NAA10 die during infancy, strongly implies that de-
fective Naa10 and impaired Nt-acetylation is lethal for humans
[35,36]. A splice donor mutation in the NAA10 gene was found
to cause Lenz microphthalmia syndrome through dysregulation
of the retinoic acid signalling pathway [37].
The number of affected substrates, the severity of knockdown
phenotypes across several model systems and implications in
disease and development all point to a critical role of Naa10 in
normal cell function. In the present study, the zebrafish Danio
rerio was used to investigate whether Naa10 is necessary for
viability and early development in a vertebrate. We identified a
zebrafish Naa10 (zNaa10) candidate and confirmed a high de-
gree of similarity between its sequence and those of character-
ized Naa10-proteins from other species. The zNaa10-candidate
was recombinantly expressed and purified and the substrate spe-
cificity, as assessed by in vitro Nt-acetylation assays, revealed
that this protein indeed was zNaa10. The spatiotemporal expres-
sion pattern of the naa10 gene at early stages was determined
by whole-mount in situ hybridization. Finally, we knocked down
naa10 in vivo to demonstrate that it has a critical role in early
zebrafish development.
EXPERIMENTAL
Protein BLAST and phylogeny
Candidate proteins were found by entering the amino acid se-
quences of the human Naa10, Naa11, Naa20, Naa30, Naa40,
Naa50 and Naa60 proteins into the BLASTp search engine
(http://blast.ncbi.nlm.nih.gov/Blast.cgi, NCBI). Top ranked can-
didates in zebrafish were chosen based on the lowest E-value.
A phylogenetic tree with these candidates, as well as the hu-
man Naa10–Naa60 and yeast Naa10 (ARD1), Naa20 (NAT3),
Naa30 maintenance of the wild-type killer virus 3 (MAK3),
Naa40 (NAT4) and Naa50 (NAT5) was constructed in Clustal
Omega, using the neighbour joining method.
Cloning of zebrafish naa10
Total RNA was isolated from 5 days post-fertilization (dpf)
zebrafish larvae as described by Peterson and Freeman
[38]. cDNA was made using the Transcriptor Reverse Tran-
scriptase kit (Roche). naa10-specific primers (naa10- NcoI-F 5′-
CTCCATGGCATGAATATACGCAACGCACG-3′ and naa10-
Acc65I-R 5′-CTGGTACCTTAAGAGTCTGACGATGAGTC-
3′) were used to amplify the naa10 gene from the cDNA lib-
rary. The PCR product was ligated into a pJET cloning vector
[part of the CloneJet PCR cloning kit (Fermentas), using the
Quick LigationTM Kit (New England Biolabs)]. It was later sub-
cloned into the pETM41 expression vector (G. Stier, EMBL).
The pETM41 vector encodes a maltose-binding protein (MBP)
N-terminally to the insert, as well as a C-terminal His-tag. The
construct was termed pETM41-naa10 and verified by DNA se-
quencing.
Expression and purification of MBP–zNaa10 and
MBP–hNaa10
One Shot® BL21 StarTM Chemically Competent Escherichia
coli cells were transformed with pETM41–naa10 or pETM41–
NAA10 encoding the MBP–hNaa10 (human Naa10) protein [24]
and a 200 ml of culture was grown to a A600 of 0.6 (at 37 ◦C), fol-
lowed by transfer to 18 ◦C and addition of IPTG to a final concen-
tration of 1 mM. Cells were incubated at 18 ◦C in a shaker at 250
rpm for 18 h and harvested the following day by centrifugation
at 12 100 g and 4 ◦C for 15 min. Cell pellets were resuspended
in 15 ml of lysis buffer [50 mM Tris/HCl, 0.3 M NaCl, 2 mM
DTT, 1 tablet/50 ml of Complete EDTA free protease inhibitor
cocktail (Roche), pH 7.4] and sonicated for 6 × 30 s. After son-
ication, the cell lysate was centrifuged once more for 15 min at
12 100 g. The supernatant containing the soluble protein fraction
was added to a 5 ml HisTrap column (Amersham), washed with
immobilised metal ion affinity chromatography (IMAC) wash
buffer (50 mM Tris/HCl, 0.3 M NaCl, 2 mM DTT, 20 mM im-
idazole, pH 7.4) and eluted with IMAC elution buffer (same as
wash buffer, but with 350 mM imidazole). Fractions containing
recombinant protein were combined and subjected to gel filtra-
tion on a HiLoad 16/60 Superdex 75 column (Amersham) and
eluted with gel filtration buffer (50 mM Tris/HCl, 0.3 M NaCl,
1 mM DTT, pH 7.4). Protein purity was confirmed by SDS/PAGE
and Coomassie staining and concentration was checked by ab-
sorbance measurements at 280 nm.
DTNB based Nt-acetylation assay
5-5′-dithiobis (2-nitrobenzoic acid) (DTNB) reacts with free
thiol groups to give the product 2-nitro-5-benzoate (NTB2 − ),
the concentration of which can be measured spectrophotometric-
ally. Using the method of Thompson et al. [39], slightly modi-
fied [40], we quantified the formation of NTB2 − after reaction
of DTNB with an acetyltransferase assay sample. The acetyl-
transferase assay was performed by incubating purified MBP–
zNaa10 (120 nM) or MBP–hNaa10 (50 nM) in acetylation buf-
fer (50 mM Tris/HCl, 1 mM DTT, 0.2 mM EDTA, pH 8.5) with
300 μM substrate peptide (Biogenes) and 300 μM acetyl-CoA
(Sigma–Aldrich). Reactions were stopped with two times the
volume of quenching buffer (3.2 M guanidinium/HCl, 100 mM
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sodium phosphate dibasic, pH 6.8) after 10 min at 37 ◦C. To meas-
ure CoA production, DTNB (2 mM final, dissolved in 100 mM
sodium phosphate dibasic, pH 6.8 and 10 mM EDTA) was ad-
ded to the quenched reaction and the absorbance at 412 nm
was measured. Thiophenolate production was quantified assum-
ing λ = 13.7 × 103 M–1 · cm–1. Background absorbances were
determined and subtracted from the absorbance determined for
each individual reaction. Activity towards EEEIA peptide sub-
strate was defined as 100 % enzyme activity and activity towards
other peptide substrates was reported relative to this. Assays were
performed in triplicate and turnover for the limiting substrate did
not exceed 10 %.
Synthetic substrate peptides
Peptides were custom made (Biogenes), varying in their
seven N-terminal residues [DDDIAAL (corresponding to
the N-terminus of β-actin), EEEIAAL (γ -actin), SESSSKS
(high-mobility group protein A1) and MLGPEGG (heterogen-
ous nuclear ribonucleoprotein F) but had the same 17 C-terminal
residues (RWGRPVGRRRRPVRVYP[OH]). The common C-
terminal segment is identical with the adrenocorticotropic hor-
mone, with lysines replaced by arginines to ensure that no Nε-
acetylation interfered with the activity measurements.
Housing, care and microinjection of zebrafish
Animals were housed at the zebrafish facility at the Department
of Molecular Biology, University of Bergen. The facility is run
in agreement with the European Convention for the Protection of
Vertebrate Animals used for Experimental and Other Scientific
Purposes. This project was in agreement with the Norwegian
Animal Welfare Act and The Norwegian Regulation on Animal
Experimentation. No ethics committee approval was sought since
this is not required for experiments on live embryos which are
terminated within 5 dpf. Adult, spotty zebrafish were kept in
continually running, osmotically cleaned water at 28.5 ◦C on a
14/10 h light/dark cycle. Adults were fed twice daily with Artemia
larvae. Embryos were kept in an incubator in E3 medium at
28.5 ◦C for the first 5 days of life. Dead embryos were removed
and E3 medium was replaced each day. Eggs were injected at
the 1-cell stage with 1-2 pmol of morpholinos (GeneTools). For
knockdown, a naa10 morpholino oligonucleotide (MO) targeting
the splice-site between intron 2 and exon 3 of the naa10 gene was
used (sequence: 5′-GGACAGCTTTAACAAAATGAACACA-
3′). The control morpholino (Ctrl MO) used is a standard control
(sequence: 5′-CCTCTTACCTCAGTTACAATTTATA-3′). The
translation-blocking MO against naa10 was 5′-GTGCGTT-
GCGTATATTCATGTTGAC-3′, whereas that of the translation-
blocking MO against p53 was 5′-GCGCCATTGCTTTGCAA-
GAATTG-3′ and is previously validated [41].
PCR validation of naa10 splice inhibition
RNA was isolated from 1 dpf embryos and used to make a
cDNA library via reverse transcriptase, as described above. The
aforementioned naa10 primers were used to amplify naa10 from
the cDNA template. Diminished levels of naa10 transcript (629
bps) were confirmed by agarose gel electrophoresis. DNA nor-
malization/control PCR was done using the same cDNA and
primers designed for a segment of zebrafish β-actin (z-actb1-
F-: 5′-TGTTGCCACCTTAAATGGCCT-3′ and z-actb1-R: 5′-
TGTACAGAGACACCCTGGCT-3′), yielding a 454 bp product.
In situ hybridization
naa10 was amplified from cDNA using naa10-specific primers,
as mentioned above, and cloned into pCR®II TOPO vector (Invit-
rogen). The sequence and orientation of the insert was confirmed
by sequencing. Anti-sense RNA probe was synthesized using Sp6
polymerase (New England Biolabs) and digoxigenin-labelled
ribonucleotides (Roche). For the negative control, sense RNA
was synthesized using T7 polymerase (New England Biolabs).
Embryos were fixed in 4 % paraformaldehyde (PFA) overnight
at 4 ◦C. After washing with 1× PBS, embryos were dehydrated
with methanol and stored at − 20 ◦C. Rehydrated embryos were
washed with PBSTw (PBS, 0.1 % Tween, 0.2 % BSA). Twenty-
four hours post-fertilization (hpf) and older embryos were per-
meabilized with proteinase K (10 mg/ml) and post-fixed in 4 %
PFA. Embryos were pre-hybridized for 2 h in hybridization buf-
fer (50 % formamide, 5× saline-sodium citrate (SSC), 0.5 mg/ml
yeast tRNA, 50 μg/ml heparin and 0.1 % Tween-20) at 65 ◦C
and thereafter hybridized with 500 ng/ml RNA probe in hybrid-
ization buffer overnight. Washes were carried out at 65 ◦C in
50 % formamide in 2× SSCTw (2× SSC, 0.1 % Tween-20), 2×
SSCTw, thereafter 0.2× SSCTw, followed by 1× maleic acid buf-
fer, pH 7.4. Embryos were blocked at room temperature in 1×
maleic acid buffer, pH 7.4, 1 % blocking agent (Roche) prior to
overnight incubation with alkaline phosphatase conjugated anti-
digoxigenin antibody (1:2500) at 4 ◦C and then incubation with
BM Purple substrate (Roche). Embryos were cleared using Mur-
ray’s clear and imaged using a Leica m420 microscope with a
CoolSNAP-Pro digital camera (Media cybernetics).
RESULTS
The putative zebrafish Naa10 is highly similar to
Naa10 of other eukaryotes
The amino acid sequences of the known human NATs (Naa10,
Naa11, Naa20, Naa30, Naa40, Naa50 and Naa60) were entered
into the pBLAST search engine, searching the zebrafish pro-
teome. We termed top-ranked results zNaa10–zNaa60. Each
query gave an unambiguous top candidate (E-score > e-105).
Human Naa10 and Naa11 gave the same top candidate, namely
the putative zNaa10. These putative NAT sequences, along with
the human NATs and the yeast NATs [yNaa10–yNaa50 (Sac-
charomyces cerevisiae Naa)] were aligned and a phylogenetic
tree was constructed (Figure 1). This tree shows that the different
zebrafish proteins cluster along with their predicted counterparts
in yeast and human.
Using the same approach, top-ranked results for hNaa10 from
Pan troglodytes, Mus musculus, Rattus norvegicus, Danio rerio,
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Figure 1 Phylogenetic tree showing the relationship between pre-
dicted zebrafish NATs and known NATs in humans and yeast
Tree made in Clustal Omega using the neighbour joining method.
Drosophila melanogaster, C. elegans, Arabidopsis thaliana and
S. cerevisiae were aligned and residues known to be important for
substrate binding were identified (Figure 2). The sequence align-
ment confirms that the putative zebrafish Naa10 is highly similar
to human Naa10. The acetyl-CoA-binding domain (RxxGxG/A)
is entirely conserved, and the amino acid residues known to
be involved in peptide substrate binding [42] are conserved as
well. These key residues are labelled by * and include Leu22,
Glu24, Tyr26, Arg113 and Tyr139. The conservation of these
key residues indicates that Naa10 function is conserved among
eukaryotes.
Recombinant purified zNaa10 Nt-acetylates typical
Naa10-substrates
In order to show biochemically that zNaa10 indeed is a true
Naa10 orthologue, we assessed its catalytic activity. zNaa10 and
hNaa10 were purified as MBP-conjugates and tested for NAT-
activity against known Naa10 substrates, as well as substrates
known to be acetylated by Naa50 and by the NatA complex.
The purified hNaa10 protein has an in vitro catalytic preference
for acidic N-termini (aspartic acid and glutamic acid), prefer-
ring glutamic acid over aspartic acid, whereas serine-peptides
(SESS), representing classical NatA complex substrates, are
acetylated to a lower degree [24]. Purified MBP–zNaa10 dis-
plays the same order of preference as earlier shown for hNaa10
(Figure 3): EEEI is acetylated 3-fold more than the DDDI sub-
strate, which again is preferred almost 2-fold to SESS, the canon-
ical NatA substrate. MLGP, a non-NatA/Naa10 substrate in vivo,
is only poorly acetylated. This verifies that zNaa10 is a NAT of
the Naa10-type and that it has identical substrate specificity to
hNaa10 in vitro.
naa10 is expressed ubiquitously in early embryonic
stages
We determined the expression pattern of naa10 in early zebrafish
development by in situ hybridization (Figure 4). naa10 mRNA
could be detected at all stages of development from the one-
cell stage onwards (Figure 4A). The expression was found to be
ubiquitous in early embryonic stages. At 24 hpf, the expression
was found in forebrain, midbrain, hindbrain, retina, otic vescicles,
myotomes and pronephric duct, though stronger expression was
observed in the midbrain, retina and the pectoral fins (Figure 4).
At 3 dpf, pronephric duct, pectoral fins, branchial arches and the
midbrain, as well as the midbrain–hindbrain boundary, showed a
stronger expression. To ensure that the staining was specific, we
used the sense strand of the gene as a negative control (Figure 4F).
Morpholino-based knockdown of zNaa10 induces
lethality and abnormal development
To determine whether Naa10 is essential for zebrafish viabil-
ity and development, we targeted embryos with naa10-specific
splice blocking MO [1]. Initially we determined a suitable dose
of naa10 MO for knockdown studies, yielding a clear phenotype
but without significant off-target effects or mortality. A dose of
2 pmol yielded significant differences in survival between con-
trols and morphants (Student’s t-test, P < 0.05) at 24 hpf. Since
MOs may have unspecific, p53-mediated cell death as a side ef-
fect [43], we also performed co-injections with a p53 MO [41]
to see if this was the case with our splice blocking MO. Co-
injection of a p53 MO neither changed the survival rate nor the
incidence of phenotypes (Supplementary Figure S1). Injection of
an identical dose of a naa10 translation- blocking morpholino
yielded similar phenotypes as the Naa10-splice blocking MO
(Supplementary Figure S2). We performed reverse transcriptase-
PCR (RT-PCR) of 1 dpf embryos treated with 1 pmol naa10 MO
(Figure 5A). We concluded that levels of naa10 transcript were
significantly decreased in morphants. Figure 5B shows represent-
ative morphant and control embryos clearly demonstrating eye
abnormalities and reduced pigmentation. Body length measure-
ments revealed that morphants were significantly shorter than
controls (Figure 5C). We also recorded the incidence of morpho-
logical abnormalities, namely bent axes, malformed or missing
eyes or missing tails, at 2 dpf and found a markedly higher incid-
ence in morphants compared with controls (Figure 5D). Five dpf
embryos are also short and show morphological abnormalities
(Figure 6). Embryos are bent (Figure 6C), have underdeveloped
mandibles and have cardiac oedema and enlarged yolk sacs
(Figure 6D).
DISCUSSION
The comparison of known and putative Naa10 proteins from
several organisms highlights the evolutionary conservation from
budding yeast to mammals (Figure 2). Using pBLAST, we could
find no evidence of other proteins that would be probable can-
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Figure 2 Alignment of the Naa10 protein sequences from several organisms
The RxxGxG/A acetyl-CoA-binding domain is highlighted, as are Leu22, Glu24, Tyr26, Arg113 and Tyr139 (*) contributing
to substrate peptide binding. Legend: light blue: non-polar amino acid; green: polar amino acid; purple: acidic amino acid;
red: basic amino acid; turquoise: tyrosine and histidine; yellow: proline; orange: glycine.
didates for the zebrafish naa10 orthologue (E-score: 1e-126).
Predicted NAT orthologues to the other human NATs (zNaa20–
zNaa60) ranked well below zNaa10 (E-scores between e-3 and
e-19). Our database searches did not give any evidence of naa10
splice variants. zNaa10 also shows high sequence similarity to the
human paralogue, hNaa11. Naa11 is a mammal-specific Naa10
paralogue that originated from a retrotransposition event [44]. It
has a high sequence similarity to the other Naa10-type proteins
(Figure 1), but we could find no evidence of a similar paralogue
in zebrafish by searching the zebrafish proteome.
Apart from two stretches near the N-terminus in yeast, which
suggest an insertion event (as the same sequence is neither seen
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Figure 3 In vitro NAT activity of MBP–zNaa10 and MBP–hNaa10 to-
wards peptide substrates
The indicated synthetic oligopeptides were incubated with purified
MBP–zNaa10 or MBP–hNaa10 enzyme in acetylation buffer at 37 ◦C
for 10 min. Product formation using EEEIA (Naa10 substrate) as sub-
strate peptide was defined as 100 % enzyme activity for each enzyme.
The product formation using DDDIA (Naa10 substrate), SESSS (NatA
substrate) and MLGPE (Naa50/NatE substrate) as substrate peptide
was correlated to the product formation using EEEIA as substrate pep-
tide. The assays were performed in triplicate (blanks were in duplicate)
with error bars indicating S.D.
in metazoans, nor in A. thaliana), most of the zNaa10 protein
is highly conserved among all eukaryotic species investigated
(Figure 2). Of particular interest is the conserved acetyl-CoA-
binding domain RxxGxG/A (highlighted in Figure 2), as well
as Leu22, Glu24, Tyr26, Arg113 and Tyr139 (*). The latter five
amino acid residues contribute to substrate binding and cata-
lysis as demonstrated by the solved structure of the NatA com-
plex from Schizosaccharomyces pombe [42]. The conservation
of these critical motifs strongly supports zNaa10 as a candidate
for the zebrafish Naa10 homologue.
The in vitro acetylation assays verified that zNaa10 is a NAT
of the Naa10-type and that it has identical substrate specificity to
human Naa10 (Figure 3). The specificity of this non-complexed
Naa10 towards the acidic N-termini is thought to represent a
post-translational NAT-activity acetylating the actins. Based on
proteomics data in human cells, γ - and β-actin are Nt-acetylated
and are likely targets of Naa10 [24]. Some actins have acidic
N-termini in both humans and zebrafish. The strong preference
of zNaa10 for acidic N-termini in vitro suggests that it is capable
of acetylating endogenous zebrafish β- and γ -actin N-termini.
Whole-mount in situ hybridization was used to visualize the
expression pattern of naa10 at various developmental stages.
naa10 is found to be maternally expressed and is found through-
out the developing embryo (Figure 4). Especially strong staining
can be seen in eyes, myotome, fin buds and the dorsal midbrain.
As the Naa10 protein is thought to be an essential component
of the protein processing machinery in all cells, the ubiquitous
expression was expected. Given that knockdown affects eye de-
velopment (Figure 5B), it is also interesting to see that expression
in the eye is high. Recently, a study of patients with Lenz mi-
crophthalmia concluded that loss of retinoic acid signalling plays
Figure 4 Spatiotemporal expression of naa10 revealed by in situ
hybridization
Lateral view of stained embryos at 0 hpf (A), 4 hpf (B), 18 hpf (C),
24 hpf (D) and 72 hpf (E). Negative control using the sense probe at
72 hpf (F).
a role in the development of this disorder [37]. The small, under-
developed eyes seen in naa10 morphants fits with these clinical
findings.
The morpholino experiments suggested that a complete loss
of Naa10 may cause lethality. Lowering the dose to 1 pmol gave
no significant difference in mortality between treated groups,
as well as an acceptable level of overall mortality and a clear
incidence of phenotypes. Thus, this dose was chosen in further
experiments. Because of the lack of a suitable antibody against
zNaa10, we were not able to validate the translation blocking
MO at the protein level. However, RT-PCR analysis of embryos
treated with the splice blocking MO shows a significant decrease
in naa10 mRNA levels (Figure 5B). We did not observe any band
corresponding to mis- or un-spliced naa10 transcripts, but the low
level of normal naa10 transcript seen in Figure 5B indicates that
the splice blocking MO has been effective and that mis-spliced
transcript may have been degraded.
Loss of zNaa10 was associated with adverse effects on growth
and development. At 2 dpf, morphants were significantly shorter
than controls (Figure 5C) and had higher incidence of abnormal-
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Figure 5 Knockdown of naa10 leads to mortality and deformities
(A) Knockdown in injected embryos verified by RT-PCR using zNaa10-specific primers. Embryos from two independent
experiments were injected with 1 pmol MO and RNA was isolated at 1 dpf. β -Actin is used as control. (B): Two dpf embryos
show impaired growth, eye abnormalities and reduced pigmentation. (C): Body length of control and naa10 morphants
at 2 dpf. **P < 0.01 (Student’s t test). (D): Percentage of injected embryos with morphological abnormalities at 2 dpf.
Highlighted are percentages of bent embryos (red). Other abnormalities included loss of eyes or deformed eyes or other
gross morphological defects. Scale bar = 0.2 mm.
ities, such as bent spines or tails. In addition, eyes were small
and underdeveloped, and embryos showed less pigmentation. At
the later stage (5 dpf), morphants had normal pigmentation, but
were still smaller than controls and enlarged yolk sacs indicated
decreased growth and activity (Figure 6). Morphants at 5 dpf
also showed underdeveloped mandibles and pericardial oedema
(Figure 6D). How Naa10 exerts its effects on a developmental
level is not known. It is presumed to act on a large number of
substrates involved in a multitude of different cellular processes.
It was earlier established that Ogden syndrome, a rare genetic dis-
order, is caused by a mutation in NAA10 which severely inhibits
the catalytic activity of the mutant protein. One of these studies
found that cells expressing the mutant protein had reduced cell
proliferation, mediated by perturbation of the Retinoblastoma 1
pathway [35,36].
Importantly, these syndromes are caused by mutations which
render the protein dysfunctional, but still retaining some catalytic
activity. The findings of the current study are in good agreement
with the developmental importance of NAA10 inferred from the
clinical cases.
The phenotype seen in naa10 morphants has some overlap
with a more generalized, ‘monster’ phenotype, described as an
unspecific side effect of MO treatment [45]. Unspecific cell death
has also been linked to sequence-independent morpholino induc-
tion of a p53 response [43]. We believe that the similar deformit-
ies seen with both splice- and translation-blocking morpholinos
against naa10, as well as the lack of effect of a p53 MO, indic-
ates that these phenotypes are indeed specific. As Naa10, due to
its numerous substrates, is probably implicated in a multitude of
cellular processes, a generalized, multi-system knockdown phen-
otype is to be expected. Such a prediction is also supported by
the ubiquitous expression profile as revealed by in situ hybridiza-
tion. However, the exact mechanism by which naa10 knockdown
leads to this generalized developmental delay is not known. Be-
cause Naa10/NatA has so many substrates, it is likely that naa10
morphants are affected in a number of molecular pathways. This
may create a plethora of distinct and overlapping phenotypes in
several tissues. The fact that naa10 is ubiquitously expressed at
all surveyed stages of development supports this interpretation of
the phenotype.
It seems reasonable to think that a loss of actin acetylation
may be of some importance in the morphological abnormalit-
ies seen in naa10 morphants. Actin is a central component of
the cytoskeleton and is involved in cell motility during normal
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Figure 6 Morphological defects in naa10 morphants at 5 dpf
At 5 dpf, naa10 morphants had a reduced head size, underdeveloped jaws and eyes, enlarged yolk sacs, pericardial
oedema and curled tails (arrows in C and D) when compared with controls (A and B). At this stage naa10 morphants
exhibited normal pigmentation. Figure shows 5 dpf embryos injected with 1 pmol of Ctrl MO or naa10 MO. Scale bar =
0.5 mm.
development [46,47]. In yeast, the charge of the N-terminus is
functionally important in tropomyosin binding [48]. For yeast
actin, a loss of acetylation has been shown to decrease the affin-
ity of its N-terminal for myosin binding [49].
Naa10, the catalytic subunit of the major eukaryotic NAT,
is conserved among all surveyed model organisms from yeast
to humans, now including zebrafish. zNaa10 has the same sub-
strate specificity as hNaa10. This suggests that zNaa10 may have
the same molecular roles as the human Naa10 protein and that
zebrafish is a suitable model for studying the organismal and
developmental importance of this protein. Our results indicate
that Naa10 is essential for viability and normal development in
zebrafish, with knockdown resulting in severe and reproducible
phenotypes, including generalized malformations and short body
length. Given the large number of likely Naa10 substrates, large,
multi-systemic effects were expected and were also observed.
Further studies should elaborate on the distinct pathways and
molecular targets affected by naa10 MO.
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